| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |